Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization

Leukemia

Volumn 13, Issue 1, 1999, Pages 105-109

  Chang, H ^a   Bouman, D ^c   Boerkoel, C F ^d   Stewart, A K ^a   Squire, J A ^b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Chromosome 13; Deletion; FISH; Hematological malignancy; Loss of heterozygosity; Tumor suppressor gene

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 13Q; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE LOSS; HUMAN; HUMAN CELL; INTERPHASE; KARYOTYPE; MALE; MONOSOMY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032921625     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401208     Document Type: Article

References (25)

1. Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91: 3-21.
2. Dewald GW, Kyle RA, Hicks GA, Greipp PR. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 1985; 66: 380-389.
3. Gould J, Alexanian R, Goodace A, Pathak S, Hecht B, Barlogie B. Plasma cell karyotype in multiple myeloma. Blood 1988; 71: 453-456.
4. Sawyer JR, Waldron JA, Jagannath S, Barlogie B. Cytogenetic findings in 200 patients with mutiple myeloma. Cancer Genet Cytogenet 1995; 82: 41-49.
5. Zandecki M, Lai JL, Facon T. Multiple myeloma: almost all patients are cytogenetically abnormal. Br J Haematol 1996; 94: 217-227.
6. Latrielle J, Barlogie B, Gohde W, Johnston D, Drewinko B, Alexanian R. Cellular DNA content as a marker of human multiple myeloma. Blood 1980; 55: 403-108.
7. Dracopoli NC. Current Protocols in Human Genetics. John Wiley: New York, 1995.
8. Tabernero D, San Miguel JF, Garcia-Sanz R, Najera L, Garcia-Isidoro M, Perez-Simon JA, Gonzalez M, Wiegant J, Raap AK, Orfao A. Incidence of chromosome numerical changes in multiple myeloma. Am J Pathol 1996; 149: 153-161.
9. Drach J, Angerler J, Schuster J, Rothermundt C, Thalhammer R, Haas OA, Jager U, Fiegl M, Geissler K, Ludwig H, Huber H. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 1995; 86: 3915-3921.
10. Flactif M, Zandecki M, Lai JL, Bernardi F, Obein V, Banters F, Facon T. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia 1995; 9: 2109-2114.
11. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole D, Naucke S, Sawyer JR. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 1995; 86: 4250-4256.
12. Brown AG, Ross FM, Eimer MD, Steel CM, Weir-Thompson EM. Evidence for a new tumor suppressor locus (DBM) in human B cell neoplasia telomeric to the retinoblastoma gene. Nat Genet 1993; 3: 67-72.
13. Liu Y, Szekely L, Grander D, Soderhall S, Juliusson G, Gahrton G, Linder S, Einhorn S. Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proc Natl Acad Sci USA 1993; 90: 8697-8701.
14. Liu Y, Hermanson M, Grander D, Merup M, Wu X, Heyman M, Rasool O, Juliusson G, Gahrton G, Detlofsson R, Nikiforova N, Buys C, Soderhall S, Yankovsky N, Zabarovsky E, Einhorn S. 13q deletions in lymphoid malignancies. Blood 1995; 86: 1911-1915.
15. Bullrich F, Veronese ML, Kitada S, Jurlander J, Caligiuri MA, Reed JC, Croce CM. Minimal region of loss at 13q14 in B cell chronic lymphocytic leukemia. Blood 1996; 88: 3109-3115.
16. Barch M (ed). The AGT Cytogenetic Laboratory Manual, 2nd edn, New York, 1997.
17. ISCN (1995). International System for Human Cytogenetic Nomenclature. Mitelman F (ed). S Karger: New York, 1995.
18. Kalachikov S, Migliazza A, Cayanis E, Fracchiolla NS, Bonaldo MF, Lawton L, Jelenc P, Ye X, Qu X, Chien M, Hauptschein R, Gaidano G, Vitolo U, Saglio G, Resegotti L, Brodjansky V, Yankovsky N, Zhang P, Soares MB, Russo J, Edelman IS, Efstratiadis A, Dalla-Favera R, Fischer SG. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics 1997; 42: 369-377.
19. Cuneo A, Bigoni R, Roberti MG, Bardi A, Balsamo R, Piva N, Castoldi G. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization (review). Haematologica 1997; 82: 85-90.
20. Cavenee WK, White R. The genetic basis of cancer. Scientific American 1995; 272: 72-81.
21. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643-646.
22. Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C. Altered expression of the retinoblastoma gene product in human sarcomas. New Engl J Med 1990; 323: 1457-1462.
23. Stilgenbauer S, Dohner H, Bulgay-Morschel M, Weitz S, Bentz M, Lichter P. High frequency of monoallelic retinoblastoma gene deletion in B-CLL chronic lymphoid leukemia shown by interphase cytogenetics. Blood 1993; 81: 2118-2124.
24. Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G. Deletion of the retinoblastoma gene in multiple myeloma. Leukemia 1994; 8: 1280-1284.
25. Stilgenbauer S, Leupolt E, Ohl S, Wei G, Schroder M, Fischer K, Bentz M, Lichter P, Dohner H. Heterogeneity of deletions involving RB-1 and the D13S25 locus in B cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res 1995; 55: 3475-3477.